Impaired NK cell responses to pertussis and H1N1 influenza vaccine antigens in human cytomegalovirus-infected individuals

Journal of Immunology

Volumn 194, Issue 10, 2015, Pages 4657-4667

  Nielsen, Carolyn M ^a   White, Matthew J ^a   Bottomley, Christian ^a   Lusa, Chiara ^a   Rodríguez Galán, Ana ^a   Turner, Scarlett E G ^a   Goodier, Martin R ^a   Riley, Eleanor M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD57 ANTIGEN; GAMMA INTERFERON; INFLUENZA VACCINE; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 2; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2C; PERTUSSIS VACCINE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADULT; AGED; ARTICLE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DEGRANULATION; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOGENICITY; IN VITRO STUDY; INFLUENZA A (H1N1); LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SEROPREVALENCE; UNITED KINGDOM; VACCINATION REACTION; CYTOMEGALOVIRUS; EPIDEMIOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; CROSS-SECTIONAL STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FLOW CYTOMETRY; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; PERTUSSIS VACCINE; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84929120145     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1403080     Document Type: Article

References (61)

1. He, X. S., M. Draghi, K. Mahmood, T. H. Holmes, G. W. Kemble, C. L. Dekker, A. M. Arvin, P. Parham, and H. B. Greenberg. 2004. T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus. J. Clin. Invest. 114: 1812-1819.
2. Long, B. R., J. Michaelsson, C. P. Loo, W. M. Ballan, B. A. Vu, F. M. Hecht, L. L. Lanier, J. M. Chapman, and D. F. Nixon. 2008. Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus. Clin. Vaccine Immunol. 15: 120-130.
3. Horowitz, A., R. H. Behrens, L. Okell, A. R. Fooks, and E. M. Riley. 2010. NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination. J. Immunol. 185: 2808-2818.
4. Evans, J. H., A. Horowitz, M. Mehrabi, E. L. Wise, J. E. Pease, E. M. Riley, and D. M. Davis. 2011. A distinct subset of human NK cells expressing HLA-DR expand in response to IL-2 and can aid immune responses to BCG. Eur. J. Immunol. 41: 1924-1933.
5. Horowitz, A., J. C. Hafalla, E. King, J. Lusingu, D. Dekker, A. Leach, P. Moris, J. Cohen, J. Vekemans, T. Villafana, et al. 2012. Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine. J. Immunol. 188: 5054-5062.
6. White, M. J., C. M. Nielsen, R. H. McGregor, E. H. Riley, and M. R. Goodier. 2014. Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens. Immunology 142: 140-150.
7. Kramski, M., M. S. Parsons, I. Stratov, and S. J. Kent. 2013. HIV-specific antibody immunity mediated through NK cells and monocytes. Curr. HIV Res. 11: 388-406.
8. Björkström, N. K., P. Riese, F. Heuts, S. Andersson, C. Fauriat, M. A. Ivarsson, A. T. Björklund, M. Flodström-Tullberg, J. Michaëlsson, M. E. Rottenberg, et al. 2010. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 116: 3853-3864.
9. Lopez-Vergès, S., J. M. Milush, S. Pandey, V. A. York, J. Arakawa-Hoyt, H. Pircher, P. J. Norris, D. F. Nixon, and L. L. Lanier. 2010. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 116: 3865-3874.
10. Gumá, M., A. Angulo, C. Vilches, N. Gómez-Lozano, N. Malats, and M. López-Botet. 2004. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104: 3664-3671.
11. +NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 108: 14725-14732.
12. Béziat, V., O. Dalgard, T. Asselah, P. Halfon, P. Bedossa, A. Boudifa, B. Hervier, I. Theodorou, M. Martinot, P. Debré, et al. 2012. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 42: 447-457.
13. Wu, Z., C. Sinzger, G. Frascaroli, J. Reichel, C. Bayer, L. Wang, R. Schirmbeck, and T. Mertens. 2013. Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity. J. Virol. 87: 7717-7725.
14. Caligiuri, M. A. 2008. Human natural killer cells. Blood 112: 461-469.
15. Nielsen, C. M., M. J. White, M. R. Goodier, and E. M. Riley. 2013. Functional significance of CD57 expression on human NK cells and relevance to disease. Front. Immunol. 4: 422.
16. Foley, B., S. Cooley, M. R. Verneris, M. Pitt, J. Curtsinger, X. Luo, S. Lopez-Vergès, L. L. Lanier, D. Weisdorf, and J. S. Miller. 2012. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood 119: 2665-2674.
17. Foley, B., S. Cooley, M. R. Verneris, J. Curtsinger, X. Luo, E. K. Waller, C. Anasetti, D. Weisdorf, and J. S. Miller. 2012. Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen. J. Immunol. 189: 5082-5088.
18. Trzonkowski, P., J. Mÿliwska, E. Szmit, J. Wieckiewicz, K. Lukaszuk, L. B. Brydak, M. Machała, and A. Mÿliwski. 2003. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination - an impact of immunosenescence. Vaccine 21: 3826-3836.
19. Moro-García, M. A., R. Alonso-Arias, A. López-Vázquez, F. M. Suárez-García, J. J. Solano-Jaurrieta, J. Baltar, and C. López-Larrea. 2012. Relationship between functional ability in older people, immune system status, and intensity of response to CMV. Age (Dordr.) 34: 479-495.
20. Wald, A., S. Selke, A. Magaret, and M. Boeckh. 2013. Impact of human cytomegalovirus (CMV) infection on immune response to pandemic 2009 H1N1 influenza vaccine in healthy adults. J. Med. Virol. 85: 1557-1560.
21. Derhovanessian, E., H. Theeten, K. Hähnel, P. Van Damme, N. Cools, and G. Pawelec. 2013. Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination. Vaccine 31: 685-690.
22. Turner, J. E., J. P. Campbell, K. M. Edwards, L. J. Howarth, G. Pawelec, S. Aldred, P. Moss, M. T. Drayson, V. E. Burns, and J. A. Bosch. 2014. Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults. Age (Dordr.) 36: 287-297.
23. Terrazzini, N., M. Bajwa, S. Vita, D. Thomas, H. Smith, R. Vescovini, P. Sansoni, and F. Kern. 2014. Cytomegalovirus infection modulates the phenotype and functional profile of the T-cell immune response to mycobacterial antigens in older life. Exp. Gerontol. 54: 94-100.
24. Miles, D. J., M. Sanneh, B. Holder, S. Crozier, S. Nyamweya, E. S. Touray, M. S. Palmero, S. M. Zaman, S. Rowland-Jones, M. van der Sande, and H. Whittle. 2008. Cytomegalovirus infection induces T-cell differentiation without impairing antigen-specific responses in Gambian infants. Immunology 124: 388-400.
25. Holder, B., D. J. Miles, S. Kaye, S. Crozier, N. I. Mohammed, N. O. Duah, E. Roberts, O. Ojuola, M. S. Palmero, E. S. Touray, et al. 2010. Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants. PLoS ONE 5: e14013.
26. den Elzen, W. P., A. C. Vossen, H. J. Cools, R. G. Westendorp, A. C. Kroes, and J. Gussekloo. 2011. Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. Vaccine 29: 4869-4874.
27. O'Connor, D., J. Trück, R. Lazarus, E. A. Clutterbuck, M. Voysey, K. Jeffery, and A. J. Pollard. 2014. The effect of chronic cytomegalovirus infection on pneumococcal vaccine responses. J. Infect. Dis. 209: 1635-1641.
28. Lefevre, E. A., B. V. Carr, C. F. Inman, H. Prentice, I. H. Brown, S. M. Brookes, F. Garcon, M. L. Hill, M. Iqbal, R. A. Elderfield, et al COSI. 2012. Immune responses in pigs vaccinated with adjuvanted and non-adjuvanted A(H1N1)pdm/09 influenza vaccines used in human immunization programmes. PLoS ONE 7: e32400.
29. Miyashita, R., N. Tsuchiya, K. Hikami, K. Kuroki, T. Fukazawa, M. Bijl, C. G. Kallenberg, H. Hashimoto, T. Yabe, and K. Tokunaga. 2004. Molecular genetic analyses of human NKG2C (KLRC2) gene deletion. Int. Immunol. 16: 163-168.
30. Goodier, M. R., M. J. White, A. Darboe, C. M. Nielsen, A. Goncalves, C. Bottomley, S. E. Moore, and E. M. Riley. 2014. Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions. Blood 124: 2213-2222.
31. Alter, G., J. M. Malenfant, and M. Altfeld. 2004. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294: 15-22.
32. Artavanis-Tsakonas, K., and E. M. Riley. 2002. Innate immune response to malaria: rapid induction of IFN-gamma from human NK cells by live Plasmodium falciparum-infected erythrocytes. J. Immunol. 169: 2956-2963.
33. Higgins, S. C., A. G. Jarnicki, E. C. Lavelle, and K. H. Mills. 2006. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 177: 7980-7989.
34. Wong, J. P., M. E. Christopher, S. Viswanathan, N. Karpoff, X. Dai, D. Das, L. Q. Sun, M. Wang, and A. M. Salazar. 2009. Activation of toll-like receptor signaling pathway for protection against influenza virus infection. Vaccine 27: 3481-3483.
35. Lee, N., C. K. Wong, D. S. Hui, S. K. Lee, R. Y. Wong, K. L. Ngai, M. C. Chan, Y. J. Chu, A. W. Ho, G. C. Lui, et al. 2013. Role of human Toll-like receptors in naturally occurring influenza A infections. Influenza Other Respi. Viruses 7: 666-675.
36. Moreno, G., A. Errea, L. Van Maele, R. Roberts, H. Léger, J. C. Sirard, A. Benecke, M. Rumbo, and D. Hozbor. 2013. Toll-like receptor 4 orchestrates neutrophil recruitment into airways during the first hours of Bordetella pertussis infection. Microbes Infect. 15: 708-718.
37. Gayoso, I., B. Sanchez-Correa, C. Campos, C. Alonso, A. Pera, J. G. Casado, S. Morgado, R. Tarazona, and R. Solana. 2011. Immunosenescence of human natural killer cells. J. Innate Immun. 3: 337-343.
38. Noyola, D. E., C. Fortuny, A. Muntasell, A. Noguera-Julian, C. Muñoz-Almagro, A. Alarcón, T. Juncosa, M. Moraru, C. Vilches, and M. López-Botet. 2012. Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children. Eur. J. Immunol. 42: 3256-3266.
39. Muntasell, A., M. López-Montañés, A. Vera, G. Heredia, N. Romo, J. Peñafiel, M. Moraru, J. Vila, C. Vilches, and M. López-Botet. 2013. NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus. Eur. J. Immunol. 43: 3268-3278.
40. Fehniger, T. A., M. H. Shah, M. J. Turner, J. B. VanDeusen, S. P. Whitman, M. A. Cooper, K. Suzuki, M. Wechser, F. Goodsaid, and M. A. Caligiuri. 1999. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J. Immunol. 162: 4511-4520.
41. Newman, K. C., and E. M. Riley. 2007. Whatever turns you on: accessory-celldependent activation of NK cells by pathogens. Nat. Rev. Immunol. 7: 279-291.
42. Lee, S. H., M. F. Fragoso, and C. A. Biron. 2012. Cutting edge: a novel mechanism bridging innate and adaptive immunity: IL-12 induction of CD25 to form high-affinity IL-2 receptors on NK cells. J. Immunol. 189: 2712-2716.
43. Brassard, D. L., M. J. Grace, and R. W. Bordens. 2002. Interferon-alpha as an immunotherapeutic protein. J. Leukoc. Biol. 71: 565-581.
44. Hansen, M. L., A. Woetmann, T. Krejsgaard, K. L. Kopp, R. Søkilde, T. Litman, P. T. Straten, C. Geisler, M. A. Wasik, N. Odum, and K. W. Eriksen. 2011. IFN-a primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity. Mol. Immunol. 48: 2087-2093.
45. Gratama, J. W., H. C. Kluin-Nelemans, R. A. Langelaar, G. J. den Ottolander, T. Stijnen, J. D'Amaro, R. Torensma, and H. J. Tanke. 1988. Flow cytometric and morphologic studies of HNK1+ (Leu 7+) lymphocytes in relation to cytomegalovirus carrier status. Clin. Exp. Immunol. 74: 190-195.
46. Luetke-Eversloh, M., Q. Hammer, P. Durek, K. Nordström, G. Gasparoni, M. Pink, A. Hamann, J. Walter, H. D. Chang, J. Dong, and C. Romagnani. 2014. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog. 10: e1004441.
47. Le Garff-Tavernier, M., V. Béziat, J. Decocq, V. Siguret, F. Gandjbakhch, E. Pautas, P. Debré, H. Merle-Beral, and V. Vieillard. 2010. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell 9: 527-535.
48. Campos, C., A. Pera, B. Sanchez-Correa, C. Alonso, I. Lopez-Fernandez, S. Morgado, R. Tarazona, and R. Solana. 2014. Effect of age and CMV on NK cell subpopulations. Exp. Gerontol. 54: 130-137.
49. Son, Y. I., R. M. Dallal, R. B. Mailliard, S. Egawa, Z. L. Jonak, and M. T. Lotze. 2001. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells. Cancer Res. 61: 884-888.
50. Wang, K. S., D. A. Frank, and J. Ritz. 2000. Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. Blood 95: 3183-3190.
51. Wu, C. Y., M. Gadina, K. Wang, J. O'Shea, and R. A. Seder. 2000. Cytokine regulation of IL-12 receptor beta2 expression: differential effects on human T and NK cells. Eur. J. Immunol. 30: 1364-1374.
52. Leong, J. W., J. M. Chase, R. Romee, S. E. Schneider, R. P. Sullivan, M. A. Cooper, and T. A. Fehniger. 2014. Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells. Biol. Blood Marrow Transplant. 20: 463-473.
53. Kunikata, T., K. Torigoe, S. Ushio, T. Okura, C. Ushio, H. Yamauchi, M. Ikeda, H. Ikegami, and M. Kurimoto. 1998. Constitutive and induced IL-18 receptor expression by various peripheral blood cell subsets as determined by anti-hIL-18R monoclonal antibody. Cell. Immunol. 189: 135-143.
54. Trotta, R., L. Chen, D. Ciarlariello, S. Josyula, C. Mao, S. Costinean, L. Yu, J. P. Butchar, S. Tridandapani, C. M. Croce, and M. A. Caligiuri. 2012. miR-155 regulates IFN-g production in natural killer cells. Blood 119: 3478-3485.
55. Simanek, A. M., J. B. Dowd, G. Pawelec, D. Melzer, A. Dutta, and A. E. Aiello. 2011. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS ONE 6: e16103.
56. Gompels, U. A., N. Larke, M. Sanz-Ramos, M. Bates, K. Musonda, D. Manno, J. Siame, M. Monze, and S. Filteau, CIGNIS Study Group. 2012. Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia. Clin. Infect. Dis. 54: 434-442.
57. Pawelec, G., and E. Derhovanessian. 2011. Role of CMV in immune senescence. Virus Res. 157: 175-179.
58. O'Hara, G. A., S. P. Welten, P. Klenerman, and R. Arens. 2012. Memory T cell inflation: understanding cause and effect. Trends Immunol. 33: 84-90.
59. Muntasell, A., C. Vilches, A. Angulo, and M. López-Botet. 2013. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction. Eur. J. Immunol. 43: 1133-1141.
60. Vyse, A. J., L. M. Hesketh, and R. G. Pebody. 2009. The burden of infection with cytomegalovirus in England and Wales: how many women are infected in pregnancy? Epidemiol. Infect. 137: 526-533.
61. Dowd, J. B., A. E. Aiello, and D. E. Alley. 2009. Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiol. Infect. 137: 58-65.